Drugs / JWXYJN
JWXYJN
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01467804 | Nov 2011 → Nov 2012 | major depressive disorder | Su Rui | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JWXYJN | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01467804 ↗ |
| Known as | Jia Wei Xiao Yao Jiaonang | “Randomized Double Blinding Controlled Study on" Jia Wei Xiao Yao Jiaonang" Treating Mild to Moderate Major Depressive Disorder” NCT01467804 ↗ |
| Known as | JWXY | “Patients are randomized to JWXY and sertraline treatment groups” NCT01467804 ↗ |
| Known as | JWXY capsule | “who take the JWXY capsule, and placebo of Sertraline, for 2 months” NCT01467804 ↗ |
| Route | Oral | “or oral JWXYJN plus placebo of sertraline daily for 2 months” NCT01467804 ↗ |